Investment Thesis
Select Medical faces deteriorating fundamentals despite modest revenue growth of 5.1% YoY. Net income declined 31.8% YoY while the company generated negative free cash flow of -$21.0M, indicating operational stress and cash burn. Combined with weak interest coverage (1.9x), minimal cash reserves ($25.7M), and extremely low returns on assets (0.7%) and equity (2.5%), the company lacks the financial strength to support its debt burden and execute sustainable operations.
Strengths
- Positive revenue growth of 5.1% YoY demonstrates market demand in healthcare services sector
- Maintained positive operating cash flow of $37.9M despite operational challenges
- Debt-to-equity ratio of 1.05x shows moderate leverage levels for the sector
Risks
- Net income collapsed 31.8% YoY with EPS down 30.1%, indicating severe margin compression and operational deterioration
- Negative free cash flow of -$21.0M shows company is burning cash despite positive OCF, unsustainable long-term
- Interest coverage ratio of only 1.9x leaves minimal buffer for debt service; high refinance risk
- Cash position of $25.7M is critically low relative to $1.8B long-term debt, creating liquidity vulnerability
- ROE of 2.5% and ROA of 0.7% indicate extremely poor capital efficiency and value destruction
Key Metrics to Watch
- Quarterly net income trend and operating margin recovery
- Free cash flow generation and cash balance sustainability
- Interest coverage ratio and debt refinancing activities
- Revenue growth sustainability and profitability recovery path
Financial Metrics
Revenue
1.4B
Net Income
44.0M
EPS (Diluted)
$0.35
Free Cash Flow
-21.0M
Total Assets
6.0B
Cash
25.7M
Profitability Ratios
Gross Margin
N/A
Operating Margin
6.9%
Net Margin
3.1%
ROE
2.5%
ROA
0.7%
FCF Margin
-1.5%
Balance Sheet & Liquidity
Current Ratio
1.15x
Quick Ratio
1.15x
Debt/Equity
1.05x
Debt/Assets
65.1%
Interest Coverage
1.94x
Long-term Debt
1.8B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T18:52:01.289114 |
Data as of: 2026-03-31 |
Powered by Claude AI